These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 9682980)

  • 1. p53 expression in oral precancer as a marker for malignant potential.
    Murti PR; Warnakulasuriya KA; Johnson NW; Bhonsle RB; Gupta PC; Daftary DK; Mehta FS
    J Oral Pathol Med; 1998 May; 27(5):191-6. PubMed ID: 9682980
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overexpression of p53 protein in betel- and tobacco-related human oral dysplasia and squamous-cell carcinoma in India.
    Kaur J; Srivastava A; Ralhan R
    Int J Cancer; 1994 Aug; 58(3):340-5. PubMed ID: 8050814
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proliferative activity and loss of function of tumour suppressor genes as 'biomarkers' in diagnosis and prognosis of benign and preneoplastic oral lesions and oral squamous cell carcinoma.
    Girod SC; Pfeiffer P; Ries J; Pape HD
    Br J Oral Maxillofac Surg; 1998 Aug; 36(4):252-60. PubMed ID: 9762452
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlation between p53 gene mutations and circulating antibodies in betel- and tobacco-consuming North Indian population.
    Ralhan R; Agarwal S; Nath N; Mathur M; Wasylyk B; Srivastava A
    Oral Oncol; 2001 Apr; 37(3):243-50. PubMed ID: 11287278
    [TBL] [Abstract][Full Text] [Related]  

  • 5. p53 expression in oral precancer and cancer.
    Rich AM; Kerdpon D; Reade PC
    Aust Dent J; 1999 Jun; 44(2):103-5. PubMed ID: 10452165
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Accumulation of the p53 tumor-suppressor gene product in oral leukoplakia.
    Wood MW; Medina JE; Thompson GC; Houck JR; Min KW
    Otolaryngol Head Neck Surg; 1994 Dec; 111(6):758-63. PubMed ID: 7527509
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High frequency of hypermethylation of p14, p15 and p16 in oral pre-cancerous lesions associated with betel-quid chewing in Sri Lanka.
    Takeshima M; Saitoh M; Kusano K; Nagayasu H; Kurashige Y; Malsantha M; Arakawa T; Takuma T; Chiba I; Kaku T; Shibata T; Abiko Y
    J Oral Pathol Med; 2008 Sep; 37(8):475-9. PubMed ID: 18284544
    [TBL] [Abstract][Full Text] [Related]  

  • 8. p53 and Ki 67 expression in preneoplastic and neoplastic lesions of the oral mucosa.
    Girod SC; Krueger G; Pape HD
    Int J Oral Maxillofac Surg; 1993 Oct; 22(5):285-8. PubMed ID: 8245568
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of aberrant p53 and p21(WAF1) immunoreactivity with the outcome of oral verrucous leukoplakia in Taiwan.
    Chang KW; Lin SC; Kwan PC; Wong YK
    J Oral Pathol Med; 2000 Feb; 29(2):56-62. PubMed ID: 10718400
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of survivin and p53 in human oral cancer: correlation with clinicopathologic findings.
    Khan Z; Tiwari RP; Mulherkar R; Sah NK; Prasad GB; Shrivastava BR; Bisen PS
    Head Neck; 2009 Aug; 31(8):1039-48. PubMed ID: 19340865
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overexpression of p53 protein in squamous cell carcinoma of buccal mucosa and tongue in Taiwan: an immunohistochemical and clinicopathological study.
    Yan JJ; Tzeng CC; Jin YT
    J Oral Pathol Med; 1996 Feb; 25(2):55-9. PubMed ID: 8667256
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lack of molecular markers to predict malignant potential of oral precancer.
    Warnakulasuriya S
    J Pathol; 2000 Mar; 190(4):407-9. PubMed ID: 10699986
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Co-overexpression of p53 and c-myc proteins linked with advanced stages of betel- and tobacco-related oral squamous cell carcinomas from eastern India.
    Baral R; Patnaik S; Das BR
    Eur J Oral Sci; 1998 Oct; 106(5):907-13. PubMed ID: 9786319
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of p53 mutant nuclear phosphoprotein in oral carcinoma and potentially malignant oral lesions.
    Warnakulasuriya KA; Johnson NW
    J Oral Pathol Med; 1992 Oct; 21(9):404-8. PubMed ID: 1432735
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Immunohistochemical analysis of the p53 tumor suppressor gene product in oral leukoplakia].
    Kikegawa A
    Kokubyo Gakkai Zasshi; 2001 Mar; 68(1):51-9. PubMed ID: 11321806
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of MDM2-P2 transcripts correlates with stabilized wild-type p53 in betel- and tobacco-related human oral cancer.
    Ralhan R; Sandhya A; Meera M; Bohdan W; Nootan SK
    Am J Pathol; 2000 Aug; 157(2):587-96. PubMed ID: 10934161
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic Abnormalities in Oral Leukoplakia and Oral Cancer Progression.
    Kil TJ; Kim HS; Kim HJ; Nam W; Cha IH
    Asian Pac J Cancer Prev; 2016; 17(6):3001-6. PubMed ID: 27356725
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Longitudinal study of TP53 mutations in eight patients with potentially malignant oral mucosal disorders.
    Ogmundsdóttir HM; Hilmarsdóttir H; Björnsson J; Holbrook WP
    J Oral Pathol Med; 2009 Oct; 38(9):716-21. PubMed ID: 19473449
    [TBL] [Abstract][Full Text] [Related]  

  • 19. p53 protein expression in sequential biopsies of oral dysplasias and in situ carcinomas.
    Regezi JA; Zarbo RJ; Regev E; Pisanty S; Silverman S; Gazit D
    J Oral Pathol Med; 1995 Jan; 24(1):18-22. PubMed ID: 7722917
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Development of precancerous lesions and the incidence of oral cancer].
    Ripari M; Maggiore C; Sottili G; Germani G; Rossi F
    Dent Cadmos; 1985 May; 53(9):63-8, 71-2. PubMed ID: 3867549
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.